Cahill Represents Initial Purchasers in $1.3 Billion Notes Offering by Ortho-Clinical Diagnostics
Date: 05/16/14
Cahill represented the joint book-running managers and the co-managers in connection with the Rule 144A offering of $1,300,000,000 aggregate principal amount of 6.625% Senior Notes due 2022 by Crimson Merger Sub, Inc. to be merged with and into Ortho-Clinical Diagnostics, Inc. upon consummation of the acquisition of Ortho-Clinical Diagnostics by The Carlyle Group from Johnson & Johnson. Proceeds from the offering were deposited into escrow pending closing of the acquisition.